Topic - Johnson & Johnson

Related Stories

New York Jets quarterback Aaron Rodgers is seen before the start of an NFL preseason football game between the Washington Commanders and New York Jets Saturday, Aug. 10, 2024, in East Rutherford. N.J. (AP Photo/Pamela Smith)

Rodgers says in book he regrets his 2021 ‘immunized’ comment

Associated Press

Supreme Court’s Purdue Pharma ruling gives ammunition to victims in bankruptcy cases

By Alex Swoyer - The Washington Times

FILE - The Johnson & Johnson headquarters in New Brunswick, New Jersey, on February 8, 2024. South African authorities have dropped an investigation into Johnson & Johnson for alleged anti-competitive practices after the company agreed not to enforce its patent on a critical TB medication, a move that should allow generic producers to make the drug at much lower prices. (AP Photo/Ted Shaffrey)

South Africa drops probe of J&J after it agrees to lower price of TB drug and withdraws patent

Associated Press

Students attend a “Dermatology Career Prep” session to encourage more minorities to become dermatologists at George Washington University’s Milken Institute School of Public Health on Thursday, June 27, 2024. (Photo by Lizzy Donker / The Washington Times)

George Washington University event aims to train diverse cadre of dermatology students

By Lizzy Donker - The Washington Times

FILE - Johnson & Johnson Consumer Health in Flourtown, Pa., Friday, April 28, 2023. A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement to cover allegations that its baby powder containing talc caused ovarian cancer. J&J said that the reorganization plan for the subsidiary that was being announced on Wednesday, May 1, 2024, was significantly different from the previous reorganization that was announced. (AP Photo/Matt Rourke)

J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits

By Michelle Chapman - Associated Press

FILE - A sign for Johnson & Johnson Consumer Health is displayed in Flourtown, Pa., Friday, April 28, 2023. The Washington state attorney general announced a $149.5 million settlement Wednesday, Jan. 24, 2024, with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role in the opioid addiction crisis. (AP Photo/Matt Rourke, File)

Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisis

By Hallie Golden - Associated Press

Johnson & Johnson is getting rid of its script logo after more than 130 years

By Tom Murphy - Associated Press

Big Pharma’s Johnson & Johnson under investigation in South Africa over ‘excessive’ drug prices

By Gerald Imray - Associated Press

A man walks by Pfizer headquarters, Friday, Feb. 5, 2021, in New York. (AP Photo/Mark Lennihan, File)

Big Pharma’s outrageous, despicable multibillion-dollar tax dodge

By Cheryl K. Chumley - The Washington Times

A bottle of Johnson's baby powder is displayed on April 15, 2011, in San Francisco. Johnson & Johnson is earmarking nearly $9 billion to cover allegations that its baby power containing talc caused cancer, more than quadrupling the amount that the company had previously set aside to pay for its potential liability. Under a proposal announced Tuesday, April 4, 2023, a J&J subsidiary will re-file for Chapter 11 bankruptcy protection and seek court approval for a plan that would result in one of the largest product-liability settlements in U.S. history. (AP Photo/Jeff Chiu, File)

J&J proposes $8.9 billion deal to settle claims about its talc-based powder

By Tom Howell Jr. - The Washington Times